March 30, 2015 / Press Release
Increasing costs and variability in health care have made the industry ripe for disruption and new technologies that will change how cardiovascular care is provided. That’s the message two opening session speakers, Peter Fitzgerald, MD, PhD, of Stanford University, and Christian Assad-Kottner, MD, of the Fogarty Institute for Innovation and El Camino Hospital in Mountain View, Calif., will share during the opening session of the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions in San Diego, May 6-9. Read more.
March 24, 2015 / President's Message
Over the past several days we have achieved major advancement in the ability of interventional cardiologists to care for higher-risk patients who have limited options through conventional therapies (medical or surgical). A combination of approvals from the Food & Drug Administration and new data announced during ACC.15 have expanded both the knowledge and tools we can use to provide therapies shown to save lives and enhance quality of life. Summarized below are recent advancements that interventional cardiologists and our Heart Teams can use to deliver optimal care for our patients. Keep reading.
March 24, 2015 / SCAI 2015 News
This year, as part of a major theme running through its educational sessions, SCAI 2015 will feature a brand-new opening session on State-of- the-Art Technologies. The session will include two presentations, given by Christian Assad-Kottner, MD, and by Peter J. Fitzgerald, MD, PhD, each examining how potentially disruptive technology may impact invasive/interventional cardiology. Continue reading.
March 24, 2015 / Press Release
As congenital heart disease (CHD) treatment advances, children with these conditions are living into adulthood, and over time, they may need additional treatment. A new expert consensus paper released today by the Society for Cardiovascular Angiography and Interventions (SCAI), American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), and The Society of Thoracic Surgeons (STS) provides guidance on transcatheter pulmonic valve replacement, or tPVR, for children and adults who were previously treated for CHD. Continue reading.